Adverse cutaneous drug reaction

Indian Journal of Dermatology

Volumn 53, Issue 1, 2008, Pages 2-8

  Nayak, Surajit ^a   Acharjya, Basanti ^a  

^a MKCG MEDICAL COLLEGE   (India)

Author keywords

ACDR; Adverse drug reactions; Steven Johnson syndrome; Toxic epidermal necrolysis

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; AYURVEDIC DRUG; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CARBAMAZEPINE; CEFUROXIME; CONTRAST MEDIUM; CORTICOSTEROID; COTRIMOXAZOLE; ERYTHROMYCIN; FAS LIGAND; LIDOCAINE; METHOTREXATE; NEUROLEPTIC AGENT; PENICILLIN G; PHENYTOIN; PRIMAQUINE; SULFONAMIDE; THEOPHYLLINE; THYMOCYTE ANTIBODY; UNINDEXED DRUG; VACCINE;

ANAPHYLAXIS; CLINICAL PRACTICE; CONTACT DERMATITIS; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRESS SYNDROME; DRUG ERUPTION; DRUG EXPOSURE; DRUG OVERDOSE; DRUG WITHDRAWAL; ERYTHEMA MULTIFORME; ERYTHRODERMA; EXFOLIATIVE DERMATITIS; FIXED DRUG ERUPTION; FOLLICULITIS; HEMOLYTIC ANEMIA; HUMAN; HYPERTENSION; LABORATORY TEST; LIVER TOXICITY; LUPUS LIKE SYNDROME; MACULOPAPULAR RASH; MEASLES LIKE RASH; MEDICAL LITERATURE; MORBIDITY; MORTALITY; PATCH TEST; PNEUMONIA; PREVALENCE; PRICK TEST; PUSTULAR PSORIASIS; REVIEW; SEIZURE; SERUM SICKNESS; SKIN BIOPSY; SKIN CULTURE; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; SYMPTOMATOLOGY; THRUSH; TINNITUS; TOXIC EPIDERMAL NECROLYSIS; XEROSTOMIA;

EID: 42549159434     PISSN: 00195154     EISSN: 19983611     Source Type: Journal    
DOI: 10.4103/0019-5154.39732     Document Type: Review

References (28)

1. Executive summary of disease management of drug hypersensitivity: A practice parameter. Joint Taskforce on Practice Parameters, the American Academy of Allergy, Asthma and Immunology and the Joint Council of Allergy, Asthma and Immunology. Ann Allergy Asthma Immunol 1999;83:665-700.
2. DeShazo RD, Kemp SF. Allergic reactions to drugs and biologic agents. JAMA 1997;278:1895-906.
3. Anderson JA, Adkinson NF Jr. Allergic reactions to drugs and biologic agents. JAMA 1987;258:2891-9.
4. Hertl M, Merk HF. Lymphocyte activation in cutaneous drug reactions. J Invest Dermatol 1995;105:95S-8S.
5. Yawalkar N, Egli F, Hari Y, Nievergelt H, Braathen LR, Pichler WJ. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions. Clin Exp Allergy 2000;30:847-55.
6. Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients: A systematic review of the prospective and retrospective studies. Bandolier Extra 2002:1-16.
7. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol 2001;137:765-70.
8. Craig KS, Edward WC, Anthony AG. Cutaneous drug reactions. Pharmacol Rev 2001;53:357-79.
9. Noel MV, Sushma M, Guido S. Cutaneous adverse drug reactions in hospitalized patients in a tertiary care centre. Indian J Pharmacol 2004;36:292-5.
10. Uppal R, Jhaj R, Malhotra S. Adverse drug reactions among in patients in a north Indian referral hospital. Natl Med J India 2000;13:16-8.
11. Jhaj R, Uppal R, Malhotra S, Bhargava VK. Cutaneous adverse reactions in in-patients in a tertiary care hospital. Indian J Dermatol Venereol Leprol 1999;65:14-7.
12. Pudukadan D, Thappa DM. Adverse cutaneous drug reactions: Clinical pattern and causative agents in a tertiary care center in South India. Indian J Dermatol Venereal Leprol 2004;70:20-4.
13. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 1998;279:1200-5.
14. Chatterjee S, Ghosh AP, Barbhuiya J, Dey SK. Adverse cutaneous drug reactions: A one year survey at a dermatology outpatient clinic of a tertiary care hospital. Indian J Pharmacol 2006;38:429-31.
15. Gruchalla R. Understanding drug allergies. J Allergy Clin Immunol 2000;105:S637-44
16. Roujeau JC, Stern RS. Severe adverse cutaneous reactions to drugs. N Engl J Med 1994;331:1272-85.
17. Ajayi FO, Sun H, Perry J. Adverse drug reactions: A review of relevant factors. J Clin Pharmacol 2000;40:1093-101.
18. th ed. McGraw-Hill: New York; 1999. p. 1634-42.
19. Sullivan JR, Shear NH. Drug eruptions and other adverse drug effects in aged skin. Clin Geriatr Med 2002;18:21-42.
20. Kauppinen K, Stubb S. Drug eruptions: Causative agents and clinical types. Acta Derm Venereol 1984;64:320-4.
21. Sharma VK, Sethuraman G, Kumar B. Cutaneous adverse drug reactions: Clinical pattern and causative agents: A six-year series from Chandigarh, India. J Postgrad Med 2001;47:95-9.
22. Pudukadan D, Thappa DM. Adverse cutaneous drug reactions: Clinical pattern and causative agents in a tertiary care center in South India. Indian J Dermatol Venereol Leprol 2004;70:20-4.
23. th ed. McGraw-Hill: New York; 1999. p. 1634-42.
24. Romagosa R, Kapoor S, Sanders J, Berman B. Inpatient adverse cutaneous drug eruptions and eosinophilia. Arch Dermatol 2001;137:511-2.
25. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for cutaneous adverse drug reactions. J Am Acad Dermatol 1996;35:458-61.
26. Shepherd GM. Allergy to beta-lactam antibiotics. Immunol Allergy Clin North Am 1991;11:611-33.
27. Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol 1995;74:167-70.
28. Adams LE, Hess EV. Drug-related lupus. Incidence, mechanisms and clinical implications. Drug Saf 1991;6:431-49.